<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=580450&amp;fmt=gif">
Get a Quote
Start an Evaluation
Menu
Get a Quote
Start an Evaluation
neoteryx-corporate-offices

about neoteryx
 

Exterior photo of Neoteryx corporate headquarters building

Our Mission

Neoteryx delivers on the promise of blood microsampling innovation. We are focused on delivering simple, quantitative microsampling solutions for biological samples, amenable to downstream automation. Our customers work to advance pharmaceutical development, personalized medicine, biotechnology research and clinical diagnostics.

Who is Neoteryx? | Video
Close up photo of a blood drop from a finger prick being collected by a Mitra Microsampling tip

Our Technology 

Our class I exempt medical device, The Mitra® microsampler, is based on Volumetric Absorptive Microsampling (VAMS™) technology. It facilitates convenient specimen collection and transportation of blood and other biological fluids to improve animal and patient welfare, reduce laboratory costs, and enable new value-based, patient-centered models of care.

Download Product Brochure

Our history

Incubated at Phenomenex for four years, the research and development of Volumetric Absorptive Microsampling (VAMS™) technology occurred with the cooperation of global pharmaceutical companies. VAMS simplifies the collection, storage, and transportation of blood samples through the instrument known as the Mitra® Microsampling Device, introduced by Neoteryx in 2014. Mitra devices accurately collect microliters of  biological fluid in seconds, without volumetric blood hematocrit bias.

Photo of a mock-up prototype model of what would become the revolutionary DBS device the Mitra Microsampler

2009

A chat over the limitations of Dried Blood Spot (DBS) cards between Dr. James Rudge (Phenomenex) and Dr. Neil Spooner (GlaxoSmithKline) reveals the market potential for a next generation dried blood microsampling technology.

Interior image of 2 assembly workers at Neoteryx manufacturing facility.

2014

10 µL devices based on VAMS™ technology are thoroughly tested by five leading pharmaceutical organizations, validating that they collect fixed volumes of blood while eliminating the volumetric hematocrit bias associated with DBS cards. Neoteryx is born!

CE and IVD symbols

2015

As a CE-IVD registered device, Neoteryx is prepared to introduce the in vitro diagnostic European market to next generation dried blood collection and transportation.

Group of presenters at the London Microsampling workshop

Neoteryx expands into the United Kingdom to better serve its growing European customer base.

The Mitra Clamshell with 4 sampler tips.

2016

The Mitra® microsampler is listed as an FDA Class 1 exempt medical device.

The Mitra Clamshell with 4 sampler tips in a laboratory setting

Responding to customer demand for a higher-volume specimen, Neoteryx releases 20 µL Mitra® microsamplers.

Interior of Neoteryx Building 2, manufacturing facility storage units

Manufacturing expands into a new building - Neo 2 - to better accommodate the growing need to manufacture more of this technology.

Collecting a blood drop from finger a finger prick in home setting

2017

Mitra® devices gain wider acceptance through projects by some of the biggest names health, research, and medicine - Quest Diagnostics, Charles River Labs, Exagen Diagnostics, and Duke University, to name a few.

close up of a 30 microliter tip

2018

With the release of the 30 µL tips, users of Mitra® devices now collect more blood. This facilitates detection of analytes with low blood concentrations and multiplex analyses from one sampler tip.

Close up of 10 microliter tips collecting blood from a finger

Increasing awareness of the VAMS™ advantage leads to a host of groundbreaking research. including breakthroughs in measuring HbA1c in diabetic patients, advances in therapeutic drug monitoring and clinical trials, and opening new care pathways in remote patient monitoring.

Exterior image of Neoteryx 3 building with Neoteryx logo
To accommodate an expanding team in Torrance, California, Neoteryx opens a new building, christened Neo 3.
Interior office shot of Neoteryx Netherlands

2019

To further meet the needs of the European market, Neoteryx opens Neoteryx B.V. in Maastricht, the Netherlands.

60th-mitra-vams-publication_v2

At only five years old, VAMS rides a wave of commercial and academic interest to rack up its 65th publication.

Close up image of a finger with a blood drop forming after its been punctured with a lancet

Increased use of microsampling in patient monitoring drives exploration of new health and wellness applications, with a focus on drug and alcohol testing.

Latest news